Guidance on Mitigating the Risk of Transmitting Respiratory Infections During Nebulization by the COPD Foundation Nebulizer Consortium

By sjmartinez • November 19, 2023

Biney I, Ari A, Barjaktarevic IZ, Carlin B, Christiani DC, Cochran L, Drummond MB, Johnson K, Kealing D, Kuehl PJ, Li J, Mahler DA, Martinez S, Ohar J, Radonovich L, Sood A, Suggett J, Tal-Singer R, Tashkin D, Yates J, Cambridge L, Dailey PA, Mannino DM, Dhand R. Guidance on Mitigating the Risk of Transmitting Respiratory Infections During Nebulization by the COPD Foundation Nebulizer Consortium. Chest. 2023 Nov 15:S0012-3692(23)05708-2. doi: 10.1016/j.chest.2023.11.013. Epub ahead of print. PMID: 37977263.

Tags: Aerosol, Aerosol dispersion, Aerosol-generating procedure, Bioaerosols, covid-19, Fugitive aerosols, Nebulizer, occupational exposure, Publications, Pulmonary, Critical Care & Sleep Medicine

ATS Core Curriculum 2026 Adult Pulmonary Medicine: Pulmonary Hypertension Diagnosis and Management

Cho JL, Camac E, Bernardo RJ, Carmona H, Del Valle KT, Forbes LM, Kolaitis NA, Mathai SK, Maximous SI, Melamed KH, Peck TJ, Soffler M,[...]

Polycyclic aromatic hydrocarbons, gut microbiome composition, impulsivity, and attention covary in a human cohort

Hammer AJ, Kasschau KD, Davis Ii EW, Hoffman P, Johnson-Camacho K, Alexiev A, Anderson K, Shannon J, Marriott LK, Sharpton TJ. Polycyclic aromatic hydrocarbons, gut[...]

Effects of Empagliflozin on Cardiovascular Outcomes Are Consistent Across Sociodemographic Subgroups: A Real-World Analysis From the EMPRISE Study

Cromer SJ, Tesfaye H, Cho H, Wexler DJ, Ortega-Montiel J, Schmedt N, Shay CM, Paik JM, Patorno E. Effects of Empagliflozin on Cardiovascular Outcomes Are[...]